Evidence map›Paper›PMID 35209035›Full record

ArticleMolecules (Basel, Switzerland)2022

Mammalian Cell Spheroids on Mixed Organic-Inorganic Superhydrophobic Coating.

Michele Ferrari, Francesca Cirisano, M Carmen Morán

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Michele FerrariCNR-ICMATE Istituto di Chimica della Materia Condensata e di Tecnologie per l'Energia, via De Marini, 6, 16149 Genova, Italy.ORCID 0000-0001-6370-605X
Francesca CirisanoCNR-ICMATE Istituto di Chimica della Materia Condensata e di Tecnologie per l'Energia, via De Marini, 6, 16149 Genova, Italy.ORCID 0000-0003-3781-8466
M Carmen MoránInstitut de Nanociència i Nanotecnologia-IN2UB, Universitat de Barcelona, Avda. Diagonal, 645, 08028 Barcelona, Spain.ORCID 0000-0003-2336-9540
Institute of Condensed Matter Chemistry and Technologies for Energy · ITInstitut de Nanociència i Nanotecnologia de la Universitat de Barcelona

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three-dimensional cell culture has become a reliable method for reproducing in vitro cellular growth in more realistic physiological conditions. The surface hydrophobicity strongly influences the promotion of cell aggregate formation. In particular, for spheroid formation, highly water-repellent coatings seem to be required for the significant effects of the process. In this work, surfaces at different wettability have been compared to observe their influence on the growth and promotion of aggregates of representative mammalian cell lines, both tumoral and non-tumoral (3T3, HaCat and MCF-7 cell lines). The effect of increased hydrophobicity from TCPS to agarose hydrogel to mixed organic-inorganic superhydrophobic (SH) coating has been investigated by optical and fluorescence microscopy, and by 3D confocal profilometry, in a time scale of 24 h. The results show the role of less wettable substrates in inducing the formation of spheroid-like cell aggregates at a higher degree of sphericity for the studied cell lines.

Indexed as

Cell Culture TechniquesCell Proliferation3T3 CellsAnimalsHumansHydrogelsHydrophobic and Hydrophilic InteractionsMCF-7 CellsMiceSpheroids, CellularHydrogels3D profilometryagarosecircularitymammalian cellssize distributionspheroidssuperhydrophobic

Identifiers

PMID35209035
PMCPMC8878059
OpenAlexW4212829959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.